Study guide

8.3 Infection Management & Antimicrobial Stewardship

DHA Pharmacist Licensing Assessment PHO5481

Track your progress as you read

Finished sections get a check mark.

1 Exam Overview & Licensing Pathway

1.1 Current Exam Facts & Format 1.2 Eligibility, PQR & the Sheryan Application Process 1.3 Study Strategy & Test-Day Plan

2 Cardiovascular Pharmacology

2.1 Antihypertensives & RAAS Agents 2.2 Heart Failure & Antiarrhythmic Drugs 2.3 Lipid-Lowering & Antianginal Agents

3 Endocrine & Metabolic Pharmacology

3.1 Insulin & Oral Antidiabetic Agents 3.2 Thyroid, Bone & Calcium Agents 3.3 Corticosteroids & Other Hormonal Agents

4 Anti-Infective Pharmacology

4.1 Beta-Lactam Antibiotics 4.2 Non-Beta-Lactam Antibacterials 4.3 Antifungals, Antivirals & Antituberculars

5 CNS, Psychiatric & Pain Pharmacology

5.1 Psychiatric Pharmacology 5.2 Antiepileptics & Neurologic Agents 5.3 Analgesics: NSAIDs, Opioids & Migraine

6 Respiratory, GI & Hematology Pharmacology

6.1 Respiratory Pharmacology 6.2 Gastrointestinal Pharmacology 6.3 Anticoagulants, Antiplatelets & Hematology Agents

7 Pharmaceutical Care: Cardiometabolic Disease

7.1 Diabetes Management & Counseling 7.2 Hypertension & Dyslipidemia Management 7.3 Heart Failure & Anticoagulation Management

8 Pharmaceutical Care: Respiratory, Rheumatology & Infection

8.1 Asthma & COPD Management 8.2 Gout, Pain & Rheumatologic Care 8.3 Infection Management & Antimicrobial Stewardship

9 Counseling, Monitoring & Special Populations

9.1 Patient Counseling, Adherence & Health Literacy 9.2 Therapeutic Monitoring & Laboratory Interpretation 9.3 Pregnancy, Pediatrics, Geriatrics & Organ Impairment 9.4 Pharmacoeconomics & Formulary Decision Making

10 Pharmaceutical Calculations I

10.1 Concentration, Ratio & Percentage Strength 10.2 Weight-Based & BSA Dosing 10.3 Dilution, Concentration & Alligation

11 Pharmaceutical Calculations II

11.1 Infusion Rates & IV Flow Calculations 11.2 Dispensing Quantities & Days' Supply 11.3 Compounding Calculations, Isotonicity & Milliequivalents

12 UAE Pharmacy Law & Regulation

12.1 UAE Regulatory Framework & Licensing Authorities 12.2 Medicine Registration, Pricing & Supply Chain 12.3 Prescription Requirements & Validity

13 Controlled Drugs, Ethics & Pharmacovigilance

13.1 Controlled & Semi-Controlled Medicines in the UAE 13.2 Ethics, Confidentiality & Generic Substitution 13.3 Pharmacovigilance, Recall & Medicine Disposal

14 Pharmacokinetics I: ADME

14.1 Absorption & Bioavailability 14.2 Distribution & Protein Binding 14.3 Metabolism & Elimination

15 Pharmacokinetics II: Kinetics, Dosing & TDM

15.1 Half-Life, Clearance & Kinetic Order 15.2 Loading & Maintenance Dosing 15.3 Therapeutic Drug Monitoring

16 OTC Medicines & Self-Care

16.1 Cough, Cold & Allergic Rhinitis 16.2 GI Self-Care: Heartburn, Constipation & Diarrhoea 16.3 Pain & Fever Self-Care 16.4 Referral Red Flags, Emergency Contraception & Skin

17 Medication Safety

17.1 High-Alert Medications & Error-Prone Abbreviations 17.2 Medication Reconciliation & Duplicate Therapy 17.3 Adverse Drug Reactions & Hypersensitivity Recognition

18 Sterile & Nonsterile Compounding

18.1 Aseptic Technique & Compounding Environments 18.2 Parenteral, TPN & Cytotoxic Preparation 18.3 Nonsterile Compounding

19 Pharmaceutics, Biopharmaceutics & Toxicology

19.1 Dosage Form Design & the Biopharmaceutics Classification System 19.2 Dissolution & Excipients 19.3 Toxicology: Poisoning Recognition & Antidotes

20 Infection Control, Natural Products, Medicinal Chemistry & Pharmacogenomics

20.1 Infection Control & Immunization 20.2 Pharmacognosy & Dietary Supplements 20.3 Medicinal Chemistry Essentials 20.4 Clinical Pharmacogenomics

8.3 Infection Management & Antimicrobial Stewardship

Key Takeaways Explain This Topic AI

Community-acquired pneumonia is treated empirically with amoxicillin (e.g., 500 mg three times daily for 5 days), adding or switching to a macrolide or doxycycline for atypical cover or penicillin allergy

Uncomplicated UTI in non-pregnant women: nitrofurantoin for 3 days is first line; avoid it when eGFR is below 30, and avoid fluoroquinolones as routine empiric therapy

Take cultures before antibiotics whenever feasible without delaying treatment in sepsis, and verify allergy histories — most reported penicillin allergies are not true allergies on assessment

IV-to-oral switch is appropriate once the patient is afebrile and haemodynamically stable, tolerating oral intake with a functioning gut, and clinically improving

In the UAE, antibiotics are prescription-only medicines — dispensing without a valid prescription is prohibited, and pharmacists are front-line stewards of right drug, dose, route, and duration

Last updated: August 2026

Common Community Infections: Empiric Choices and Durations

Empiric therapy follows the likely pathogens, local resistance patterns, allergy status, and patient factors such as pregnancy and renal function. Typical NICE-aligned first-line regimens to know for the exam:

  • Infection First-line empiric choice Typical duration
  • Community-acquired pneumonia (low severity) Amoxicillin 500 mg three times daily 5 days
  • Uncomplicated UTI (non-pregnant women) Nitrofurantoin 100 mg modified-release twice daily 3 days
  • Cellulitis (non-purulent) Flucloxacillin 500 mg four times daily 5–7 days
  • Acute sinusitis / otitis media Analgesia first; delayed antibiotic if needed 5 days if used

Community-acquired pneumonia (CAP) : assess severity first — the CRB-65 score (confusion, respiratory rate, blood pressure, age 65 or over) guides whether the patient is managed in the community or admitted. Amoxicillin is first line for low-severity CAP; add or switch to a macrolide (clarithromycin) or doxycycline for atypical pathogens or penicillin allergy. Stop at 5 days when the patient is clinically stable, and advise that cough and fatigue can persist for weeks after the infection clears.

Urinary tract infection (UTI) : nitrofurantoin for 3 days is first line in non-pregnant women (avoid when eGFR is below 30, where it may fail and accumulate). Trimethoprim for 3 days is an alternative where local resistance is low. In pregnancy , use nitrofurantoin (avoided at term because of neonatal haemolysis risk), cefalexin, or amoxicillin-clavulanate guided by culture, typically for 7 days, and always send a urine culture. Reserve fluoroquinolones — routine empiric ciprofloxacin is discouraged because of rising resistance and serious adverse effects. Men with UTI need longer courses and investigation for underlying causes.

Cellulitis : flucloxacillin covers the usual streptococci and Staphylococcus aureus; clarithromycin is the standard penicillin-allergy alternative. Mark the skin edge, elevate the limb, and review response at 48–72 hours.

Sinusitis and acute otitis media are mostly viral and self-limiting : offer analgesia (paracetamol or ibuprofen) and saline, and use a delayed (back-up) prescription to be collected only if symptoms worsen or fail to settle; antibiotics are reserved for severe illness, symptoms lasting more than about 10 days without improvement, or bilateral otitis with discharge in young children, where amoxicillin for 5 days is typical. Sore throat is similarly usually viral — tools such as FeverPAIN or Centor criteria identify the minority who may benefit from phenoxymethylpenicillin.

Core Prescribing Principles

Culture before antibiotic : obtain mid-stream urine, sputum, or blood cultures before the first dose whenever feasible, because cultures guide de-escalation — but never delay treatment in suspected sepsis, where every hour matters.

Verify the allergy history : distinguish true allergy (urticaria, angioedema, anaphylaxis) from intolerance (nausea, diarrhoea, headache). Up to 90–95% of recorded penicillin allergy labels are not confirmed on formal assessment, and unverified labels push patients onto broader, costlier, and less effective agents. Document the drug, the reaction, its timing, and its severity.

Renal dose adjustment : check renal function for renally cleared agents; recall nitrofurantoin is avoided below an eGFR of 30, and many beta-lactams need dose or interval changes in impairment.

IV-to-oral switch criteria : the patient is afebrile and haemodynamically stable for 24–48 hours, tolerating oral intake with a functioning gastrointestinal tract, and clinically improving with falling inflammatory markers — then switch to a suitable oral agent. Agents with excellent oral bioavailability (for example fluoroquinolones, linezolid, or metronidazole) are particularly easy switches. Early switch shortens stay, reduces line infections, and cuts cost.

Antimicrobial Stewardship

Antimicrobial stewardship (AMS) means the right drug, at the right dose, by the right route, for the right duration , and it matters because antimicrobial resistance is a leading global health threat driven by unnecessary and inappropriate use:

Start with the narrowest effective spectrum; de-escalate once culture and sensitivity results return, and build in an antibiotic review (time-out) at 48–72 hours for every inpatient prescription.

Restrict broad-spectrum agents (carbapenems, piperacillin-tazobactam) to defined indications to preserve their utility.

Prefer the shortest effective duration — for many common infections, 5 days is enough.

C. difficile awareness : broad-spectrum exposure — especially clindamycin, cephalosporins, and fluoroquinolones — disrupts protective gut flora and predisposes to Clostridioides difficile infection; narrow agents and short courses limit this risk.

Counsel every patient: take doses as directed, complete the course, do not share antibiotics, and do not keep leftovers. Practical points matter too — nitrofurantoin with food, doxycycline upright with plenty of water and sun protection.

Vaccination as prevention : influenza and pneumococcal vaccination reduce infections and therefore antibiotic demand — stewardship starts before the first prescription.

The Pharmacist's Stewardship Role in the UAE

In the UAE, antibiotics are prescription-only medicines : dispensing any systemic antibiotic without a valid prescription is prohibited and actively enforced by health authorities (MOHAP, DHA, DOH), with penalties for non-compliant pharmacies. Community pharmacists act as gatekeepers — refusing non-prescription requests, verifying prescription validity, counseling on adherence, and redirecting patients with viral illnesses to symptomatic care and safety-netting advice. Hospital pharmacists contribute to antimicrobial stewardship programmes through formulary restriction, local guideline development, prospective audit and feedback, dose optimisation (renal adjustment and therapeutic drug monitoring), IV-to-oral switch prompts, and review of local antibiograms. Both roles are core examinable stewardship competencies.